Progyny Inc. (PGNY)
NASDAQ: PGNY
· Real-Time Price · USD
20.51
-0.38 (-1.82%)
At close: May 23, 2025, 3:59 PM
20.45
-0.29%
After-hours: May 23, 2025, 04:10 PM EDT
Progyny Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|
| Fertility benefit services revenue Revenue | 729.55M | 676.29M | 510.14M | 355.62M |
| Fertility benefit services revenue Revenue Growth | +7.87% | +32.57% | +43.45% | n/a |
| Pharmacy benefit services revenue Revenue | 437.67M | 412.3M | 276.77M | 145M |
| Pharmacy benefit services revenue Revenue Growth | +6.15% | +48.97% | +90.87% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 51.63M | 47.65M | 46.79M | 47.59M | 43.88M | 43.09M | 44.44M | 45.46M | 43.63M | 41.19M | 34.74M | 35.05M | 33.01M | 25.3M | 19.43M | 17.96M | 17.1M | 19.5M | 15.47M | 13.78M | 12.74M | 10.63M | 9.25M | 9.1M | 6.85M | 6.12M | 5.63M | 5.36M | 5.78M |
| Selling, General, and Administrative Revenue Growth | +8.35% | +1.84% | -1.70% | +8.46% | +1.83% | -3.02% | -2.25% | +4.19% | +5.93% | +18.56% | -0.88% | +6.19% | +30.45% | +30.25% | +8.14% | +5.06% | -12.33% | +26.04% | +12.34% | +8.10% | +19.93% | +14.85% | +1.68% | +32.74% | +12.03% | +8.59% | +5.21% | -7.34% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 17.79M | 15.62M | 16.46M | 16.42M | 15.45M | 14.91M | 14.91M | 15.38M | 14.28M | 12.98M | 11.17M | 11.5M | 10.02M | 7.7M | 4.44M | 4.03M | 4.01M | 4.78M | 3.35M | 3.61M | 3.27M | 3.25M | 3.18M | 3.12M | 2.35M | 2.14M | 1.65M | 1.73M | 1.76M |
| Sales and Marketing Revenue Growth | +13.90% | -5.11% | +0.22% | +6.26% | +3.64% | 0.00% | -3.07% | +7.72% | +10.03% | +16.25% | -2.87% | +14.79% | +30.13% | +73.29% | +10.25% | +0.35% | -15.95% | +42.35% | -7.01% | +10.44% | +0.37% | +2.26% | +2.12% | +32.86% | +9.47% | +30.04% | -4.79% | -1.82% | n/a |